Milhealth's Directory of Military Health Information Resources

Long-Chain -3 Fatty Acids for Indicated Prevention of Psychotic Disorders

Long-Chain -3 Fatty Acids for Indicated Prevention of Psychotic Disorders

A Randomized, Placebo-Controlled Trial

G. Paul Amminger, MD; Miriam R. Schäfer, MD; Konstantinos Papageorgiou, MD; Claudia M. Klier, MD; Sue M. Cotton, PhD; Susan M. Harrigan, MSc; Andrew Mackinnon, PhD; Patrick D. McGorry, MD, PhD; Gregor E. Berger, MD

Arch Gen Psychiatry. 2010;67(2):146-154.

Context The use of antipsychotic medication for the prevention of psychotic disorders is controversial. Long-chain -3 (omega-3) polyunsaturated fatty acids (PUFAs) may be beneficial in a range of psychiatric conditions, including schizophrenia. Given that -3 PUFAs are generally beneficial to health and without clinically relevant adverse effects, their preventive use in psychosis merits investigation.

TRIAP and TAMP: Web based behavioral health care

TRIAP – (TRICARE Assistance Program) & TAMP (Transition Assistance Management Program)

The web-based TRICARE Assistance Program (TRIAP) Demonstration began on August 1, 2009 in the U.S. and will continue until April 1, 2010. The purpose of the demonstration is to test the use of web-based technologies to:

• Deliver information and counseling services to our beneficiaries
• Determine if web-based technologies increases efficiency of identifying beneficiaries who need behavioral health care
• Identify behavioral health needs of our beneficiaries earlier
• Refer and get beneficiaries access to the appropriate level of behavioral health care more effectively.